Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2022


      News provided by

      Ellomay Capital Ltd

      Mar 31, 2023, 10:00 ET

      Share this article

      Share this article


      TEL-AVIV, Israel, March 31, 2023 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the fourth quarter and year ended December 31, 2022.

      Financial Highlights for the Year Ended December 31, 2022

      • Revenues were approximately €53.4[1] million for the year ended December 31, 2022, compared to approximately €45.7 million for the year ended December 31, 2021. This increase mainly results from the substantial increase in electricity prices in Spain and the connection to the grid of Ellomay Solar, a 28 MW photovoltaic facility in Spain ("Ellomay Solar") during June 2022, upon which the Company commenced recognition of revenues.

      [1] The revenues are based on IFRS and do not take into account the adjustments included in the Company's investor presentation.  

      • Operating expenses were approximately €24.1 million for the year ended December 31, 2022, compared to approximately €17.6 million for the year ended December 31, 2021. The increase in operating expenses mainly results from the implementation of the Spanish RDL 17/2021, commencing September 16, 2021 and currently in effect until December 31, 2023, that established the reduction of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. The increase in operating expenses also resulted from the Company's biogas operations in the Netherlands that were impacted by the military conflict between Russia and Ukraine causing shortages in certain raw materials and an increase in delivery prices, and from the connection to the grid of Ellomay Solar during June 2022, upon which the Company commenced recognition of expenses. Depreciation expenses were approximately €16.1 million for the year ended December 31, 2022, compared to approximately €15.1 million for the year ended December 31, 2021. The increase in depreciation and amortization expenses is mainly attributable to the commencement of recognition of results of Ellomay Solar upon connection to the Spanish grid in June 2022.
      • Project development costs were approximately €3.8 million for the year ended December 31, 2022, compared to approximately €2.5 million for the year ended December 31, 2021. The increase in project development costs is mainly due to development expenses in connection with photovoltaic projects in Italy and Israel.
      • General and administrative expenses were approximately €5.9 million for the year ended December 31, 2022, compared to approximately €5.7 million for the year ended December 31, 2021. The increase is mostly due to an increase in the management fee paid pursuant to the new Management Services Agreement effective July 1, 2021, and an increase in salaries paid to employees.
      • The Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €1.2 million for the year ended December 31, 2022, compared to approximately €0.12 million for the year ended December 31, 2021. The increase in share of profits of equity accounted investee was mainly due to the increase in revenues of Dorad Energy Ltd. ("Dorad") due to higher quantities produced and a higher electricity tariff, partially offset by an increase in operating expenses in connection with the increased production and higher tariff.
      • Financing expenses, net were approximately €2.5 million for the year ended December 31, 2022, compared to approximately €26.9 million for the year ended December 31, 2021. The decrease in financing expenses, net, was mainly attributable to income resulting from exchange rate differences amounting to approximately €6 million in the year ended December 31, 2022, mainly in connection with the New Israeli Shekel ("NIS") cash and cash equivalents and the Company's NIS denominated debentures, compared to expenses in the amount of approximately €5.4 million for the year ended December 31, 2021, caused by (i) the 6.6% devaluation of the NIS against the euro during the year ended December 31, 2022, compared to the 10.8% revaluation of the NIS against the euro during the year ended December 31, 2021, and (ii) expenses recorded in 2021 of approximately €0.8 million in connection with the early repayment of the Company's Series B Debentures. In addition, during the year ended December 31, 2021, we recorded financing expenses in the amount of approximately €12.2 million in connection with the amortization of the outstanding balance of expenses that were capitalized to the previous financing of Talasol Solar S.L.U ("Talasol"), our majority owned subsidiary (51%) that owns a photovoltaic plant with a peak capacity of 300 MW in the municipality of Talaván, Cáceres, Spain ("Talasol PV Plant") in connection with a refinancing of its debt and approximately €3.3 million recorded in connection with the termination of an interest rate swap contract.
      • Taxes on income were approximately €2.1 million in the year ended December 31, 2022, compared to a tax benefit of approximately €2.3 million in the year ended December 31, 2021. The tax increase is mainly due to the substantial increase in electricity prices in Spain, resulting in higher taxable income of the Company's Spanish subsidiaries.
      • Net profit was approximately €0.1 million in the year ended December 31, 2022, compared to net loss of approximately €19.6 million for the year ended December 31, 2021.
      • Total other comprehensive loss was approximately €35.3 million for the year ended December 31, 2022, compared to total other comprehensive loss of approximately €4.5 million in the year ended December 31, 2021. The increase in total other comprehensive loss mainly resulted from foreign currency translation differences on NIS denominated operations, as a result of fluctuations in the euro/NIS exchange rates and from changes in fair value of cash flow hedges, including a material increase in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol PV Plant (the "Talasol PPA").

        The Talasol PPA experienced a high volatility due to the substantial increase in electricity prices in Europe since the commencement of the military conflict between Russia and Ukraine. In accordance with hedge accounting standards, the changes in the Talasol PPA's fair value are recorded in the Company's shareholders' equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company's consolidated net profit/loss or the Company's consolidated cash flows. As the Company controls Talasol, the total impact of the changes in fair value of the Talasol PPA (including the minority share) is consolidated into the Company's financial statements and total equity. Alongside the increase in fair value of the liability in connection with the Talasol PPA, the increase in the electricity prices had, and is expected to continue to have for as long as the prices remain relatively high, a positive impact on Talasol's revenues from the sale of the capacity that is not subject to the Talasol PPA, resulting in an expected increase in Talasol's net income and cash flows.
      • Total comprehensive loss was approximately €35.2 million in the year ended December 31, 2022, compared to total comprehensive loss of approximately €24.1 million in the year ended December 31, 2021.
      • EBITDA was approximately €20.8 million for the year ended December 31, 2022, compared to approximately €20.1 million for the year ended December 31, 2021.
      • Net cash from operating activities was approximately €11.3 million for the year ended December 31, 2022, compared to net cash from operating activities of approximately €16.1 million for the year ended December 31, 2021.
      • As required under an amendment to IAS 16, "Property, Plant and Equipment" (the "IAS 16 Amendment"), the Company retrospectively applied the IAS 16 Amendment and revised the financial results as of and for the year ended December 31, 2021. The IAS 16 Amendment required the Company to recognize the results of the Talasol PV Plant commencing connection to the grid (December 2020) instead of recognizing results commencing achievement of PAC (Preliminary Acceptance Certificate), which occurred on January 27, 2021. The revisions mainly included an increase in the balance of fixed assets against a corresponding increase in retained earnings and deferred tax as of December 31, 2021, and an increase in revenues and expenses, with a corresponding decrease in tax benefit and in the net loss for the year ended December 31, 2021.

      CEO Review for 2022

      The Company's activities are divided into two main fields:

      • Development and Construction - the development of a backlog of projects in the PV field in Italy, Spain, USA and Israel, the construction of a pumped hydro storage project in the Manara Cliff in Israel and the construction of PV in Italy; and
      • Operations and Improvements - the Company manages, operates and improves its generating projects in Israel, Spain and the Netherlands (bio-gas).

      The Company's revenues for 2022 were approximately €53.3, an increase of approximately 17% in revenues compared to the same period last year. These revenues are slightly lower than the anticipated revenues for the period, mainly as during the fourth quarter of 2022 there was a decrease in electricity prices in Spain (even though such prices increased overall during 2022) and lower radiation. The average electricity price in Spain during the fourth quarter of 2022 was approximately €0.11/kWh, compared to an average price of €0.20/kWh during 2021. Due to existing regulation in Spain that effectively reduces returns on electricity generating activity to no more than approximately €0.11/kWh, the decrease in revenues did not impact the Company's operating profit. Due to lower radiation during the fourth quarter of 2022, the electricity produced by the Talasol PV Plant was lower by approximately 24,000 MW compared to the fourth quarter of 2021. The lower production impacted the electricity that is not subject to the Talasol PPA and would have been sold in market prices (approximately €0.11/kWh). 

      As a result of the lower radiation during 2022, Talasol produced approximately 33,000 MW less than its expected average annual production. Due to the existing Spanish regulation, these 33,000 MW would have been sold at an effective price of €0.11/kWh and therefore caused a decrease in gross profit of approximately €3.6 million.   

      Due to the military conflict in Ukraine, the prices of the energy, transportation and raw materials used by the biogas operations in the Netherlands increased by approximately €2.74 million compared to 2021 and the Company expects that the increase in expenses will be mitigated by higher gas and green certificate prices during 2023.

      The cash flow from operations for 2022 was approximately €11.3 million, which includes a deduction of approximately €3.3 million due to a non-recurring advance payment of income tax as per a tax assessment agreement (timing differences of payable income tax) to the Israeli Tax Authority in connection with the Talmei Yosef PV Plant and increased project development costs mainly due to the advanced development of the photovoltaic portfolio in Italy and in Israel.

      Activity in Spain: The Ellomay Solar PV plant in Spain (28 MW PV) was connected to the electricity grid towards the end of the second quarter of 2022. Commencing the third quarter of 2022, this PV plant operated at full capacity and generated revenues of approximately €3.6 million during 2022.

      The Talasol PV plant in Spain (300 MW PV), 51% held by the Company, generated revenues in the amount of approximately €33 million for 2022.

      Talasol is a party to a financial hedge of its electricity capture price (PPA) in connection with approximately 80% of its production (75% based on P-50) and the remaining electricity produced by Talasol is sold directly to the grid, currently at an average price of €0.11/kWh.

      Activity in Italy: The Company has approximately 600 MW PV projects under advanced development stages, of which licenses have been obtained for approximately 200 MW. Of these 200 MW PV projects, 20 MW are under advanced construction and the remainder (approximately 180 MW) are expected to commence construction during 2023.

      The Company has additional projects in earlier development stages and the intention is to reach a portfolio of approximately 1,000 MW PV in various degrees of development and operations by 2025.

      The Company is negotiating a financing agreement for the financing of 600 MW PV projects that are in advanced development stages with a leading European bank in the field.

      Activity in Israel:

      The Manara Pumped Storage Project (Company's share is 83.34%): The Manara Cliff pumped storage project, with a capacity of 156 MW, is in advanced construction stages and expected to reach commercial operation during the second half of 2026. The Company and the project's other shareholder, Ampa, invested the equity required for the projects, and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.

      Development of PV licenses combined with storage:

      1. The Komemiyut project, intended for 21 MW PV and 47 MW / hour batteries. The project obtained an approval for connection to the grid and is in the process of receiving a building permit. Construction is planned to commence in the third quarter of 2023.
      2. The Qelahim project, intended for 15 MW PV and 33 MW / hour batteries. The project obtained an approval for connection to the grid, and is in the final stages of the zoning approval.

        These projects are based on a tender the Company won and there is an option of transition to regulation that enables sale to end customers.

      3. The Talmei Yosef project, an expansion of the existing project (as of today 9 MW PV) to 104 dunams, intended for 10 MW PV and 22 MW / hour batteries. The request for zoning approval has been filed and approval is expected to be received in the second quarter of 2023.
      4. The Talmei Yosef storage project in batteries, which obtained zoning approval for 30 dunam, intended for approximately 400 MW / hour. The project is designed for the regulation of the high voltage storage.
      5. The Sharsheret project, intended for 20 MW PV and 44 MW / hour batteries. The zoning request for was submitted.
      6. Additional 250 dunams - under advanced planning stages.

      Dorad Power Station (Company's share is approximately 9.4%): the gas flow from the Karish reservoir began during November 2022. The gas from the Karish reservoir is expected to reduce the gas costs of Dorad. In addition, the change in the electricity tariff, which entered into force in January 2023, means an increase in the "PISGA"/ peak (high consumption) hours, and the elimination of the "GEVA" (average consumption) hours, is expected to reduce the operating expenses of the power station without decreasing the revenues.

      Activity in the Netherlands: In connection with the military conflict in Ukraine and the stoppage of Russian gas supply to Europe, there are substantial changes in the field of biogas in the Netherlands and Europe. Europe in general and the Netherlands specifically have set ambitious goals for increasing gas production from waste. Various incentives are being considered, the main one is increasing the price of the green certificates and as of today the market price of these certificates has increased from an average of 13–15 euro cents per cubic meter to around 30-45 euro cents per cubic meter and future increases are currently projected.

      The gas price for 2023, which is determined based on the 2022 average, was set at €1.13 per cubic meter, a price that is higher than the cap of the subsidy granted to the Company's Dutch subsidiaries (approximately €0.75 per cubic meter). Therefore, in 2023 and possibly also in 2024, the Dutch subsidiaries will temporarily exit the subsidy regime. Not using the subsidy during 2023 and 2024 will enable the Dutch subsidiaries to postpone the termination of the subsidy period (originally 12 years) by two years.

      On the other hand, due to the military conflict in Ukraine, during 2022 there was an increase in the price of feedstock, which is based on agricultural residues, and in the cost of transportation and the price of electricity (which increased tenfold). These circumstances caused an increase in expenses. As of the beginning of 2023, the feedstock prices and transportation costs are in decline and there is no shortage of raw material of any kind.

      The increase in electricity prices in the Netherlands did not substantially impact two of the three biogas facilities owned by the Company, which produce the electricity and heat they consume for themselves. However, the Gelderland project, which was acquired in December 2020, was not equipped with the means to self-generate electricity and heat during 2022 and was required to pay expensive prices for the electricity it consumes and to purchase expensive gas for heating, which caused an increase in expenses of approximately €1 million compared to forecasts. In May 2022, Gelderland received notification of approval for a subsidy for generation of electricity and heat in its facility, in August 2022 a generator (CHP) was ordered, which is being installed and expected to commence operating during the coming days.

      The expected increase in revenues during 2023, caused by the increase in green certificate and gas prices, combined with the expected decrease in feedstock and transportation costs and the reduction of the energy costs in the Gelderland facility are expected to improve the operating results of the biogas facilities.

      The Company estimates that with the increasing importance of the biogas field, this field entered into a new era. In the Netherlands, new legislation was adopted that obliges the gas suppliers commencing January 1, 2024 to gradually incorporate green gas in a scope of up to 20% of the amount supplied by them. This legislation, and the growing demand for green certificates from the biogas industry, is expected to add and improve the expected results of the biogas segment of the Company.

      Use of NON-IFRS Financial Measures

      EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 16 of this press release.

      About Ellomay Capital Ltd.

      Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

      To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

      • Approximately 35.9 MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
      • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
      • 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
      • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;
      • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
      • Ellomay Solar Italy One SRL and Ellomay Solar Italy Two SRL that are constructing photovoltaic plants with installed capacity of 14.8 MW and 4.95 MW respectively, in the Lazio Region, Italy; and
      • Ellomay Solar Italy Four SRL, Ellomay Solar Italy Five SRL and Ellomay Solar Italy Ten SRL that are developing photovoltaic projects with installed capacity of 15.06 MW, 87.2 MW and 18 MW respectively, in the Lazio Region, Italy that have reached "ready to build" status.

      For more information about Ellomay, visit http://www.ellomay.com.

      Information Relating to Forward-Looking Statements

      This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of continued military conflict between Russia and Ukraine, including its impact on electricity prices, availability of raw materials and disruptions in supply changes, the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

      Contact:

      Kalia Rubenbach (Weintraub)
      CFO
      Tel: +972 (3) 797-1111
      Email: [email protected]


      Ellomay Capital Ltd. and its Subsidiaries

       

      Condensed Consolidated Statements of Financial Position


      December 31,


      2022

      2021

      2022


      Unaudited

      Audited

      Unaudited


      € in thousands

      Convenience Translation
      into US$ in thousands*

      Assets




      Current assets:




      Cash and cash equivalents

      46,458

      41,229

      49,547

      Marketable securities

      2,836

      1,946

      3,025

      Short term deposits

      -

      28,410

      -

      Restricted cash

      900

      1,000

      960

      Receivable from concession project

      1,799

      1,784

      1,919

      Trade and other receivables

      12,682

      9,487

      13,525


      64,675

      83,856

      68,976

      Non-current assets




      Investment in equity accounted investee

      30,029

      34,029

      32,026

      Advances on account of investments

      2,328

      1,554

      2,483

      Receivable from concession project

      24,795

      26,909

      26,444

      Fixed assets

      365,756

        **340,897

      390,077

      Right-of-use asset

      30,020

      23,367

      32,016

      Intangible asset

      4,094

      4,762

      4,366

      Restricted cash and deposits

      20,192

      15,630

      21,535

      Deferred tax

      23,510

      12,952

      25,073

      Long term receivables

      9,270

      5,388

      9,886

      Derivatives

      1,488

      2,635

      1,587


      511,482

      468,123

      545,493





      Total assets

      576,157

      551,979

      614,469





      Liabilities and Equity




      Current liabilities




      Current maturities of long term bank loans

      12,815

      126,180

      13,667

      Current maturities of long term loans

      10,000

      16,401

      10,665

      Current maturities of debentures

      18,714

      19,806

      19,958

      Trade payables

      4,504

      2,904

      4,803

      Other payables

      11,207

      20,806

      11,952

      Current maturities of derivatives

      33,183

      14,783

      35,390

      Current maturities of lease liabilities

      745

      4,329

      795


      91,168

      205,209

      97,230

      Non-current liabilities




      Long-term lease liabilities

      22,005

      15,800

      23,468

      Long-term loans

      229,466

      39,093

      244,725

      Other long-term bank loans

      21,582

      37,221

      23,017

      Debentures

      91,714

      117,493

      97,813

      Deferred tax

      6,770

      **9,044

      7,220

      Other long-term liabilities

      2,021

      3,905

      2,155

      Derivatives

      28,354

      10,107

      30,239


      401,912

      232,663

      428,637

      Total liabilities

      493,080

      437,872

      525,867

      Equity




      Share capital

      25,633

      25,605

      27,337

      Share premium

      86,018

      85,883

      91,738

      Treasury shares

      (1,736)

      (1,736)

      (1,851)

      Transaction reserve with non-controlling Interests

      5,697

      5,697

      6,076

      Reserves

      (12,632)

      7,288

      (13,472)

      Retained earnings (accumulated deficit)

      (7,256)

      **(6,899)

      (7,738)

      Total equity attributed to shareholders of the Company

      95,724

      115,838

      102,090

      Non-Controlling Interest

      (12,647)

      **(1,731)

      (13,488)

      Total equity

      83,077

      114,107

      88,602

      Total liabilities and equity

      576,157

      551,979

      614,469

      * Convenience translation into US$ (exchange rate as at December 31, 2022: euro 1 = US$ 1.066)
      ** Restatement in connection with the retrospective application of an amendment to IAS 16 as required under the amendment.

      Ellomay Capital Ltd. and its Subsidiaries 

      Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) 


      For the three months ended December 31,

      For the year
      ended December 31,

      For the three months
      ended December 31,

      For the year
      ended December 31,



      2022

      2021

      2022

      2021

      2022

      2022


      Unaudited

      Unaudited

      Audited

      Unaudited

      Unaudited


      € in thousands (except per share data)

      Convenience Translation into US$*

      Revenues

      8,635

      **12,017

      53,360

      **45,721

      9,209

      56,908

      Operating expenses

      (5,660)

       **(5,873)

      (24,089)

      **(17,590)

      (6,036)

      (25,691)

      Depreciation and amortization expenses

      (4,241)

       **(4,038)

      (16,092)

      **(15,116)

      (4,523)

      (17,162)

      Gross profit (loss)

      (1,266)

      2,106

      13,179

      13,015

      (1,350)

      14,055








      Project development costs

      (1,104)

      (663)

      (3,784)

      (2,508)

      (1,177)

      (4,036)

      General and administrative expenses

      (926)

      (1,712)

      (5,892)

      (5,661)

      (988)

      (6,284)

      Share of profits of equity accounted investee

      650

      (167)

      1,206

      117

      693

      1,286

      Operating profit (loss)

      (2,646)

      (436)

      4,709

      4,963

      (2,822)

      5,021








      Financing income

      8,933

      585

      9,565

      2,931

      9,527

      10,201

      Financing income (expenses) in connection with derivatives and warrants, net

      (410)

      (438)

      605

      (841)

      (437)

      645

      Financing expenses in connection with projects finance

      (1,919)

      (12,276)

      (7,765)

      (17,800)

      (2,047)

      (8,281)

      Financing expenses in connection with debentures

      (799)

      (420)

      (2,130)

      (3,220)

      (852)

      (2,272)

      Interest expenses on minority shareholder loan

      (306)

      (551)

      (1,529)

      (2,055)

      (326)

      (1,631)

      Other financing expenses

      (224)

      (3,346)

      (1,212)

      (5,899)

      (239)

      (1,293)

      Financing income (expenses), net

      5,275

      (16,446)

      (2,466)

      (26,884)

      5,626

      (2,631)

      Profit (loss) before taxes on income

      2,629

      (16,882)

      2,243

      (21,921)

      2,804

      2,390

      Tax benefit (taxes on income)

      (153)

      **3,043

      (2,103)

      **2,281

      (163)

      (2,243)

      Profit (loss) for the period

      2,476

      (13,839)

      140

      (19,640)

      2,641

      147

      Profit (loss) attributable to:







      Owners of the Company

      3,429

       **(8,351)

      (357)

      **(15,090)

      3,657

      (381)

      Non-controlling interests

      (953)

       **(5,488)

      497

        **(4,550)

      (1,016)

      528

      Profit (loss) for the period

      2,476

      (13,839)

      140

      (19,640)

      2,641

      147

      Other comprehensive income (loss) items







      That after initial recognition in comprehensive income (loss)
      were or will be transferred to profit or loss:







      Foreign currency translation differences for foreign operations

      (9,035)

      6,696

      (7,829)

      12,284

      (9,635)

      (8,350)

      Effective portion of change in fair value of cash flow hedges

      35,538

      (783)

      (28,283)

      (13,429)

      37,902

      (30,163)

      Net change in fair value of cash flow hedges

      transferred to profit or loss

      -

      (1,481)

      821

      (3,353)

      -

      876

      Total other comprehensive income (loss)

      26,503

      4,432

      (35,291)

      (4,498)

      28,267

      (37,637)








      Total other comprehensive income (loss) attributable to:







      Owners of the Company

      9,582

      5,260

      (19,920)

      3,124

      10,220

      (21,244)

      Non-controlling interests

      16,921

      (828)

      (15,371)

      (7,622)

      18,047

      (16,393)

      Total other comprehensive income (loss)

      26,503

      4,432

      (35,291)

      (4,498)

      28,267

      (37,637)








      Total comprehensive income (loss) for the year

      28,979

      (9,407)

      (35,151)

      (24,138)

      30,908

      (37,490)








      Total comprehensive income (loss) for the year attributable to:







      Owners of the Company

      13,011

      (3,091)

      (20,277)

      (11,966)

      13,877

      (21,625)

      Non-controlling interests

      15,968

      (6,316)

      (14,874)

      (12,172)

      17,031

      (15,865)

      Total comprehensive income (loss) for the year

      28,979

      (9,407)

      (35,151)

      (24,138)

      30,908

      (37,490)








      Basic profit (loss) per share

      0.27

        **(0.62)

      (0.03)

        **(1.18)

      0.29

      (0.03)

      Diluted profit (loss) per share

      0.27

       ** (0.62)

      (0.03)

        **(1.18)

      0.29

      (0.03)

      * Convenience translation into US$ (exchange rate as at December 31, 2022: euro 1 = US$ 1.066)
      ** Restatement in connection with the retrospective application of an amendment to IAS 16 as required under the amendment.




      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity




      Attributable to shareholders of the Company

      Non-
      controlling

      Interests

      Total




      Equity


      Share
      capital

      Share
      premium

      Accumulated
      Deficit

      Treasury
      shares

      Translation
      reserve from
      foreign
      operations

      Hedging
      Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

      Total




      € in thousands

      For the year ended











      December 31, 2022 (Unaudited):











      Balance as at January 1, 2022

      25,605

      85,883

      (6,899)

      (1,736)

      15,365

      (8,077)

      5,697

      115,838

      (1,731)

      114,107

      Profit (loss) for the year

      -

      -

      (357)

      -

      -

      -

      -

      (357)

      497

      140

      Other comprehensive loss for the year

      -

      -

      -

      -

      (7,395)

      (12,525)

      -

      (19,920)

      (15,371)

      (35,291)

      Total comprehensive loss for the year

      -

      -

      (357)

      -

      (7,395)

      (12,525)

      -

      (20,277)

      (14,874)

      (35,151)

      Transactions with owners of the Company,
      recognized directly in equity:











      Issuance of Capital note to non-controlling interest

      -

      -

      -

      -

      -

      -

      -

      -

      3,958

      3,958

      Options exercise

      28

      8

      -

      -

      -

      -

      -

      36

      -

      36

      Share-based payments

      -

      127

      -

      -

      -

      -

      -

      127

      -

      127

      Balance as at December 31, 2022

      25,633

      86,018

      (7,256)

      (1,736)

      7,970

      (20,602)

      5,697

      95,724

      (12,647)

      83,077












      For the three months











      ended December 31, 2022 (Unaudited):











      Balance as at September 30, 2022

      25,605

      85,973

      (10,685)

      (1,736)

      16,517

      (38,731)

      5,697

      82,640

      (28,615)

      54,025

      Profit (loss) for the year

      -

      -

      3,429

      -

      -

      -

      -

      3,429

      (953)

      2,476

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      (8,547)

      18,129

      -

      9,582

      16,921

      26,503

      Total comprehensive income (loss) for the year

      -

      -

      3,429

      -

      (8,547)

      18,129

      -

      13,011

      15,968

      28,979

      Transactions with owners of the Company, recognized directly in equity:











      Options exercise

      28

      8

      -

      -

      -

      -

      -

      36

      -

      36

      Share-based payments

      -

      37

      -

      -

      -

      -

      -

      37

      -

      37

      Balance as at December 31, 2022

      25,633

      86,018

      (7,256)

      (1,736)

      7,970

      (20,602)

      5,697

      95,724

      (12,647)

      83,077




      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity


      Share capital

      Share premium

      Retained earnings

      Treasury shares

      Translation
      reserve from
      foreign
      operations

      Hedging Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

      Total




      € in thousands

      For the year ended











      December 31, 2021 (Audited):











      Balance as at











      January 1, 2021

      25,102

      82,401

      8,191

      (1,736)

      3,823

      341

      6,106

      124,228

      798

      125,026

      Loss for the year

      -

      -

        *(15,090)

      -

      -

      -

      -

      (15,090)

      (4,550)

      (19,640)

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      11,542

      (8,418)

      -

      3,124

      (7,622)

      (4,498)

      Total comprehensive income (loss) for the year

      -

      -

      (15,090)

      -

      11,542

      (8,418)

      -

      (11,966)

      (12,172)

      (24,138)

      Transactions with owners of the Company, recognized directly in equity:











      Issuance of ordinary shares

      -

      -

      -

      -

      -

      -

      -

      -

      8,682

      8,682

      Acquisition of shares in subsidiaries from non-controlling interests







      (409)

      (409)

      961

      552

      Warrants exercise

      454

      3,419






      3,873

      -

      3,873

      Options exercise

      49

      -

      -

      -

      -

      -

      -

      49

      -

      49

      Share-based payments

      -

      63

      -

      -

      -

      -

      -

      63

      -

      63

      Balance as at December 31, 2021

      25,605

      85,883

      (6,899)

      (1,736)

      15,365

      (8,077)

      5,697

      115,838

      (1,731)

      114,107












      For the three months











      ended December 31, 2021 (Unaudited):











      Balance as at











      September 30, 2021

      25,578

      85,774

      1,452

      (1,736)

      9,093

      (7,065)

      5,145

      118,241

      4,585

      122,826

      Loss for the year

      -

      -

       * (8,351)

      -

      -

      -

      -

      (8,351)

      (5,488)

      (13,839)

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      6,272

      (1,012)

      -

      5,260

      (828)

      4,432

      Total comprehensive income (loss) for the period

      -

      -

      (8,351)

      -

      6,272

      (1,012)

      -

      (3,091)

      (6,316)

      (9,407)

      Transactions with owners of the Company, recognized directly in equity:











      Acquisition of shares in subsidiaries from non-controlling interests

      -

      -

      -

      -

      -

      -

      552

      552

      -

      552

      Issuance of ordinary shares

      -

      71

      -

      -

      -

      -

      -

      71

      -

      71

      Options exercise

      27

      -

      -

      -

      -

      -

      -

      27

      -

      27

      Share-based payments

      -

      38

      -

      -

      -

      -

      -

      38

      -

      38

      Balance as at December 31, 2021

      25,605

      85,883

      (6,899)

      (1,736)

      15,365

      (8,077)

      5,697

      115,838

      (1,731)

      114,107

      ** Restatement in connection with the retrospective application of an amendment to IAS 16 as required under the amendment.




      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




      Attributable to shareholders of the Company

      Non- controlling

      Total




      Interests

      Equity


      Share capital

      Share premium

      Accumulated Deficit

      Treasury shares

      Translation
      reserve from
      foreign
      operations

      Hedging Reserve

      Interests
      Transaction
      reserve with
      non-controlling
      Interests

      Total




      Convenience translation into US$ (exchange rate as at December 31, 2021: euro 1 = US$ 1.066)

      For the year ended











      December 31, 2022 (Unaudited):











      Balance as at January 1, 2022

      27,307

      91,594

      (7,357)

      (1,851)

      16,386

      (8,614)

      6,076

      123,541

      (1,844)

      121,697

      Profit (loss) for the year

      -

      -

      (381)

      -

      -

      -

      -

      (381)

      528

      147

      Other comprehensive loss for the year

      -

      -

      -

      -

      (7,887)

      (13,357)

      -

      (21,244)

      (16,393)

      (37,637)

      Total comprehensive loss for the year

      -

      -

      (381)

      -

      (7,887)

      (13,357)

      -

      (21,625)

      (15,865)

      (37,490)

      Transactions with owners of the Company,
      recognized directly in equity:











      Issuance of Capital note to non-controlling interest

      -

      -

      -

      -

      -

      -

      -

      -

      4,221

      4,221

      Options exercise

      30

      9

      -

      -

      -

      -

      -

      39

      -

      39

      Share-based payments

      -

      135

      -

      -

      -

      -

      -

      135

      -

      135

      Balance as at December 31, 2022

      27,337

      91,738

      (7,738)

      (1,851)

      8,499

      (21,971)

      6,076

      102,090

      (13,488)

      88,602












      For the three months











      ended December 31, 2022 (Unaudited):











      Balance as at September 30, 2022

      27,307

      91,690

      (11,395)

      (1,851)

      17,614

      (41,306)

      6,076

      88,135

      (30,519)

      57,616

      Profit (loss) for the year

      -

      -

      3,657

      -

      -

      -

      -

      3,657

      (1,016)

      2,641

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      (9,115)

      19,335

      -

      10,220

      18,047

      28,267

      Total comprehensive income (loss) for the year

      -

      -

      3,657

      -

      (9,115)

      19,335

      -

      13,877

      17,031

      30,908

      Transactions with owners of the Company, recognized directly in equity:











      Options exercise

      30

      9

      -

      -

      -

      -

      -

      39

      -

      39

      Share-based payments

      -

      39

      -

      -

      -

      -

      -

      39

      -

      39

      Balance as at December 31, 2022

      27,337

      91,738

      (7,738)

      (1,851)

      8,499

      (21,971)

      6,076

      102,090

      (13,488)

      88,602

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Cash Flow


      For the three months
      ended December 31,

      For the year ended December 31,

      For the three months
      ended December 31,

      For the year ended
      December 31,


      2022

      2021

      2022

      2021

      2022

      2022


      Unaudited

      Unaudited

      Audited

      Unaudited

      Unaudited


      € in thousands

      Convenience Translation into US$*

      Cash flows from operating activities







      Profit for the period

      2,476

        **(13,839)

      140

        **(19,640)

      2,641

      147

      Adjustments for:







      Financing expenses, net

      (5,275)

      16,446

      2,466

      26,884

      (5,626)

      2,631

      Profit from settlement of derivatives contract

      -

      -

      -

      (407)

      -

      -

      Depreciation and amortization

      4,241

      **4,038

      16,092

      **15,116

      4,523

      17,162

      Share-based payment transactions

      37

      38

      127

      63

      39

      135

      Share of profits of equity accounted investees 

      (650)

      167

      (1,206)

      (117)

      (693)

      (1,286)

      Payment of interest on loan from an equity accounted investee

      -

      -

      -

      859

      -

      -

      Change in trade receivables and other receivables

      441

      4,542

      724

      (1,883)

      470

      772

      Change in other assets

      (99)

      (345)

      (209)

      (545)

      (106)

      (223)

      Change in receivables from concessions project

      (48)

      267

      (521)

      1,580

      (51)

      (556)

      Change in trade payables

      2,451

      166

      1,697

      154

      2,614

      1,810

      Change in other payables

      (591)

      (4,834)

      3,807

      2,380

      (630)

      4,060

      Tax benefit

      153

      **(3,043)

      2,103

        **(2,281)

      163

      2,243

      Income taxes paid

      (1,938)

      (79)

      (6,337)

      (94)

      (2,067)

      (6,758)

      Interest received

      493

      517

      1,896

      1,844

      526

      2,022

      Interest paid

      (4,275)

      (1,701)

      (9,459)

      (7,801)

      (4,559)

      (10,088)


      (5,060)

      16,179

      11,180

      35,752

      (5,397)

      11,924

      Net cash from (used in) operating activities

      (2,584)

      2,340

      11,320

      16,112

      (2,756)

      12,071

      Cash flows from investing activities







      Acquisition of fixed assets

      (9,543)

      (7,435)

      (48,610)

      (80,885)

      (10,178)

      (51,842)

      VAT associated with the acquisition of fixed assets

      -

      (2,310)

      -

      -

      -

      -

      Repayment of loan from an equity accounted investee

      -

      -

      149

      1,400

      -

      159

      Loan to an equity accounted investee

      (68)

      (39)

      (128)

      (335)

      (73)

      (137)

      Advances on account of investments

      (774)

      8

      (774)

      -

      (825)

      (825)

      Proceeds from marketable securities

      (1,062)

      (1,897)

      (1,062)

      (112)

      (1,133)

      (1,133)

      Proceeds from settlement of derivatives, net

      -

      (724)

      3,272

      (976)

      -

      3,490

      Proceed (investment) in restricted cash, net

      4,007

      (5,786)

      (4,873)

      (5,990)

      4,273

      (5,197)

      Investment in short term deposit

      -

      (27,132)

      27,645

      (18,599)

      -

      29,483

      Net cash used in investing activities

      (7,440)

      (45,315)

      (24,381)

      (105,497)

      (7,936)

      (26,002)

      Cash flows from financing activities







      Sale of shares in subsidiaries to non-controlling interests

      -

      32,130

      -

      1,400

      -

      -

      Proceeds from options

      36

      10,799

      36

      49

      38

      38

      Cost associated with long term loans

      3

      (35,311)

      (9,988)

      (2,796)

      3

      (10,652)

      Payment of principal of lease liabilities

      18,853

      (8,478)

      (5,703)

      (4,803)

      20,107

      (6,082)

      Proceeds from long-term loans

      -

      37,033

      215,170

      32,947

      -

      229,478

      Repayment of long-term loSans

      (5,308)

      (18,927)

      (153,751)

      (18,905)

      (5,661)

      (163,975)

      Repayment of Debentures

      -

      (29,411)

      (19,764)

      (30,730)

      -

      (21,078)

      Repayment of SWAP instrument associated with long term loans

      -

      -

      (3,290)

      -

      -

      (3,509)

      Proceeds from issue of convertible debentures

      -

      -

      -

      15,571

      -

      -

      Proceeds from issuance of Debentures, net

      -

      32,252

      -

      57,717

      -

      -

      Issuance / exercise of warrants

      -

      2,346

      -

      3,746

      -

      -

      Net cash from financing activities

      13,584

      22,433

      22,710

      54,196

      14,487

      24,220

      Effect of exchange rate fluctuations on cash and cash equivalents

      (5,589)

      3,718

      (4,420)

      9,573

      (5,959)

      (4,713)

      Increase (decrease) in cash and cash equivalents

      (2,029)

      (16,824)

      5,229

      (25,616)

      (2,164)

      5,576

      Cash and cash equivalents at the beginning of the period

      48,487

      58,053

      41,229

      66,845

      51,711

      43,971

      Cash and cash equivalents at the end of the period

      46,458

      41,229

      46,458

      41,229

      49,547

      49,547









      * Convenience translation into US$ (exchange rate as at December 31, 2022: euro 1 = US$ 1.066)

      ** Restatement in connection with the retrospective application of an amendment to IAS 16 as required under the amendment.

      Ellomay Capital Ltd. and its Subsidiaries

      Operating Segments


      PV




      Total






      Ellomay



      Bio



      reportable


      Total


      Italy

      Spain

      Solar

      Talasol

      Israel

      Gas

      Dorad

      Manara

      segments

      Reconciliations

      consolidated


      For the year ended December 31, 2022


      € in thousands













      Revenues

      -

      3,264

      3,597

      32,740

      1,119

      12,640

      62,813

      -

      116,173

      (62,813)

      53,360

      Operating expenses

      -

      (322)

      (1,399)

      (8,764)

      (418)

      (13,186)

      (47,442)

      -

      (71,531)

      47,442

      (24,089)

      Depreciation expenses

      -

      (908)

      (427)

      (11,400)

      (512)

      (2,824)

      (6,339)

      -

      (22,410)

      6,318

      (16,092)

      Gross profit (loss)

      -

      2,034

      1,771

      12,576

      189

      (3,370)

      9,032

      -

      22,232

      (9,053)

      13,179













      Adjusted Gross profit (loss)

      -

      2,034

      1,771

      12,576

      1,565[1]

      (3,370)

      9,032

      -

      23,608

      (10,429)

      13,179

      Project development costs











      (3,784)

      General and administrative expenses











      (5,892)

      Share of loss of equity accounted investee











      1,206

      Operating profit











      4,709

      Financing income











      9,565

      Financing expenses in connection












       with derivatives and warrants, net











      605

      Financing expenses, net











      (12,636)

        Profit before taxes on Income











      2,243

      Segment assets as at












       December 31, 2022

      22,608

      14,577

      20,090

      244,584

      34,750

      32,002

      107,079

      137,432

      613,122

      (36,965)

      576,157


      Ellomay Capital Ltd. and its Subsidiaries

      Reconciliation of Profit (Loss) to EBITDA


      For the three months ended December 31,

      For the year ended December 31,

      For the three months ended December 31,

      For the year ended December 31,


      2022

      2021

      2022

      2021

      2022

      2022


      € in thousands

      Convenience Translation into US$*

      Net (profit) loss for the period

      2,476

      **(13,839)

      140

      **(19,640)

      2,641

      147

      Financing expenses, net

      (5,275)

      16,446

      2,466

      26,884

      (5,626)

      2,631

      Tax benefit

      153

        **(3,043)

      2,103

        **(2,281)

      163

      2,243

      Depreciation and amortization

      4,241

        **4,038

      16,092

      **15,116

      4,523

      17,162

      EBITDA

      1,595

      3,602

      20,801

      20,079

      1,701

      22,183









      * Convenience translation into US$ (exchange rate as at December 31, 2022: euro 1 = US$ 1.066)

      ** Restatement in connection with the retrospective application of an amendment to IAS 16 as required under the amendment.

      Ellomay Capital Ltd. and its Subsidiaries

      Information for the Company's Debenture Holders

      Potential Warning Signs

      As of December 31, 2022, we had working capital deficiency of approximately €29.2 million. The working capital deficiency as of December 31, 2022, resulted from the recording of current maturities of derivatives in the amount of approximately €33.2 million as a result of the increase in the fair value of the liability resulting from the Talasol PPA. These current maturities do not impact our cash flows. Taking into account the nature of the current maturities, in our opinion our working capital is sufficient for our present requirements.

      Upon the issuance of our Debentures, we undertook to comply with the "hybrid model disclosure requirements" as determined by the Israeli Securities Authority and as described in the Israeli prospectuses published in connection with the public offering of our Debentures. This model provides that in the event certain financial "warning signs" exist in our consolidated financial results or statements, and for as long as they exist, we will be subject to certain disclosure obligations towards the holders of our Debentures. One possible "warning sign" is the existence of a working capital deficiency (if the board of directors of the company does not determine that the working capital deficiency is not an indication of a liquidity problem). In examining the existence of warning signs as of December 31, 2022, our Board of Directors noted the working capital deficiency as of December 31, 2022. Our board of directors reviewed our financial position, outstanding debt obligations and our existing and anticipated cash resources and uses and determined that the existence of a working capital deficiency as of December 31, 2022 does not indicate a liquidity problem. In making such determination, our board of directors noted the following: (i) the deficiency in working capital resulted from the recording of current maturities of derivatives in the amount of approximately €33.2 million as a result of the increase in the fair value of the liability resulting from the Talasol PPA, which does not impact our cash flow in the next 12 months as Talasol's revenues from the sale of electricity during the same period are expected to exceed its liability and payments to the PPA provider, (ii) pursuant to the applicable accounting rules, we are required to recognize the fair value of expected future payments to the PPA provider as a liability but do not recognize the expected revenues from the Talasol PV Plant as assets, as these expected revenues cannot be recorded as an asset under accounting rules, resulting in an increase in current liabilities and a working capital deficiency, and (iii) our operating subsidiaries generated a positive cash flow during the year ended December 31, 2022.

      Financial Covenants

      Pursuant to the Deeds of Trust governing the Company's Series C, Series D and Series E Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2022, and below.

      Net Financial Debt

      As of December 31, 2022, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €62.6 million (consisting of approximately €278[2] million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €111.9[3] million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021) and Series D Debentures issuance (in February 2021), net of approximately €49.3 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €278[4] million of project finance and related hedging transactions of the Company's subsidiaries).

      Information for the Company's Series C Debenture Holders.

      The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "Series C Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of December  31, 2022, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately €129.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 32.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[5], was 2.6.

      The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended December 31, 2022:


      For the four-quarter period
      ended December 31, 2022


      Unaudited


      € in thousands

      Profit for the period

      140

      Financing expenses, net

      2,466

      Taxes on income

      2,103

      Depreciation

      16,092

      Share-based payments

      127

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,427

      Adjusted EBITDA as defined the Series C Deed of Trust

      24,355

      Information for the Company's Series D Debenture Holders

      The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of December  31, 2022, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €129.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 32.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[6] was 2.3.

      The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended December 31, 2022: 


      For the four quarter period
      ended December 31, 2022


      Unaudited


      € in thousands

      Profit for the period

      140

      Financing expenses, net

      2,466

      Taxes on income

      2,103

      Depreciation and amortization expenses

      16,092

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,427

      Share-based payments

      127

      Adjustment to data relating to projects with a Commercial Operation
      Date during the four preceding quarters[7]

      2,328

      Adjusted EBITDA as defined the Series D Deed of Trust

      26,683

      Information for the Company's Series E Debenture Holders

      The Deed of Trust governing the Company's Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of December 31, 2022, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately €129.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 32.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[8] was 2.3.

      The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended December 31, 2022: 



      For the four-quarter period
      ended December 31, 2022


      Unaudited


      € in thousands

      Profit for the period

      140

      Financing expenses, net

      2,466

      Taxes on income

      2,103

      Depreciation and amortization expenses

      16,092

      Adjustment to revenues of the Talmei Yosef PV Plant due to
      calculation based on the fixed asset model

      3,427

      Share-based payments

      127

      Adjustment to data relating to projects with a Commercial Operation
      Date during the four preceding quarters[9]

      2,328

      Adjusted EBITDA as defined the Series E Deed of Trust

      26,683

      [1] The gross profit of the Talmei Yosef PV Plant located in Israel is adjusted to include income from the sale of electricity (approximately €3,427 thousand) and depreciation expenses (approximately €2,051 thousand) under the fixed asset model, which were not recognized as revenues and depreciation expenses, respectively, under the financial asset model as per IFRIC 12.  

      [2] Short-term and long-term debt from banks and other interest-bearing financial obligations amount provided above, includes an amount of approximately €4.1 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet. 

      [3] Debentures amount provided above includes an amount of approximately €1.5 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet. 

      [4] The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

      [5] The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      [6] The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      [7] The adjustment is based on the results of Ellomay Solar since June 2022.

      [8] The term "Adjusted EBITDA" is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      [9] The adjustment is based on the results of Ellomay Solar since June 2022.

      SOURCE Ellomay Capital Ltd

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.